China National Medicines Corporation Ltd. (SHA:600511)
28.86
+0.17 (0.59%)
Oct 14, 2025, 2:45 PM CST
SHA:600511 Market Cap
SHA:600511 has a market cap or net worth of 21.65 billion as of October 13, 2025. Its market cap has decreased by -1.24% in one year.
Market Cap
21.65B
Enterprise Value
15.87B
Revenue
51.47B
Ranking
n/a
PE Ratio
11.11
Stock Price
28.86
Market Cap Chart
Since November 27, 2002, SHA:600511's market cap has increased from 1.54B to 21.65B, an increase of 1,309.15%. That is a compound annual growth rate of 12.25%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 13, 2025 | 21.65B | -16.16% |
Dec 31, 2024 | 25.82B | 19.57% |
Dec 29, 2023 | 21.59B | 2.58% |
Dec 30, 2022 | 21.05B | -11.51% |
Dec 31, 2021 | 23.79B | -36.06% |
Dec 31, 2020 | 37.20B | 80.69% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Jiangsu Hengrui Medicine | 446.22B |
WuXi AppTec | 294.15B |
Shenzhen Mindray Bio-Medical Electronics | 292.67B |
Sichuan Biokin Pharmaceutical | 148.35B |
Shanghai United Imaging Healthcare | 128.25B |
Aier Eye Hospital Group | 117.68B |
Zhangzhou Pientzehuang Pharmaceutical., | 117.03B |
Yunnan Baiyao Group Co.,Ltd | 101.26B |